business / news / / STAT
AACR is the American Association of Cancer Researchers’ annual meeting.
Dana-Farber tested Carvykti CAR-T therapy in high-risk smoldering multiple myeloma patients.
KEY POINTS
- This trial represents a novel preventative use of CAR-T prior to active cancer development.
- Carvykti targets BCMA, aiming to halt progression from precursor to full multiple myeloma.
- The study involved 20 patients in an early phase clinical trial.
COMPANIES
Summarized by Newsio from STAT. How we summarize →